Literature DB >> 616047

Increased transcapillary escape rate of albumin and IgG in essential hypertension.

H H Parving, H A Jensen, M Westrup.   

Abstract

Transcapillary escape rates of albumin and IgG (fractions of intravascular mass of albumin and IgG that pass to the extravascular space per unit time) were determined simultaneously from the initial disappearance of intravenously injected 131I human albumin and 125I human IgG in seven untreated subjects suffering from essential hypertension. The average mean arterial blood pressure of these subjects 193/119 mmHg; four subjects had grade I-III funduscopic changes. Transcapillary escape rates of albumin (TERalb) and IgG (TERIgG) were found significantly increased in the hypertensive subjects, average 7.8 +/- 0.9 (SD) and 4.7 +/- 1.0 (SD) %/h, respectively, compared with normal values of mean 5.2 +/- 1.0 (SD) and 3.0 +/- 0.7 (SD) %/h, respectively (P less than 0.01). There was a statistically significant positive correlation between the mean arterial blood pressure and TER of albumin and of IgG (P less than 0.001). The TERIgG/TERalb ratio was about the same in the hypertensives and the normals. Confirming a previous observation, we found an increase in the daily urinary albumin excretion rate from a normal average of 9.1 (range, 2.4-20.4)mg/24 h to 96 (range, 5.6-565) mg/24 h, P less than 0.05. The present findings can best be explained by increased filtration through normal pores between the endothelial cells in the microvasculature, due to the high arterial blood pressure.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 616047     DOI: 10.3109/00365517709091486

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  8 in total

1.  A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.

Authors:  O Samuelsson; T Hedner; S Ljungman; H Herlitz; B Widgren; K Pennert
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Microalbuminuria.

Authors:  P H Winocour
Journal:  BMJ       Date:  1992-05-09

3.  Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability.

Authors:  Paul R V Malik; Abdullah Hamadeh; Colin Phipps; Andrea N Edginton
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-03-04       Impact factor: 2.745

4.  Urinary albumin excretion and transcapillary escape rate of albumin in malignancies.

Authors:  L M Pedersen; L Terslev; P G SŁrensen; K H Stokholm
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

Review 5.  Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer.

Authors:  Paul Malik; Colin Phipps; Andrea Edginton; Jonathan Blay
Journal:  Pharm Res       Date:  2017-09-18       Impact factor: 4.200

6.  Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension.

Authors:  C Rangemark; H Lind; L Lindholm; T Hedner; O Samuelsson
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

7.  Fibrinogen induces alterations of endothelial cell tight junction proteins.

Authors:  Phani K Patibandla; Neetu Tyagi; William L Dean; Suresh C Tyagi; Andrew M Roberts; David Lominadze
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

8.  Protection of Renal Function with ACE Inhibitors: Experience with Benazepril.

Authors:  J C Aldigier; Y L Meur; P Brunel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.